COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 269: Articles 2681-2690  | Next

Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine
Komori, M., Morey, A. L., Quinones-Molina, A. A., Fofana, J., Romero, L., Peters, E., Matsuda, K., Gummuluru, S., Smith, J. F., Akahata, W., Akiyama, H.
10.1101/2023.11.01.565056 — Posted: 2023-11-01
SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2
Niu, C., Liang, T., Chen, Y., Zhu, S., Zhou, L., Chen, N., Qian, L., Wang, Y., Li, M., Zhou, X., Cui, J.
10.1101/2023.11.01.565098 — Posted: 2023-11-01
Projections of wastewater as an indicator of COVID-19 cases in corrections facilities: a modelling study
Han, D., Linares, P., Holm, R. H., Chandran, K., Smith, T. R.
10.1101/2023.10.31.23296864 — Posted: 2023-10-31
Systematic SARS-CoV-2 S Gene Sequencing in Wastewater Samples Enables Early Lineage Detection and Uncovers Rare Mutations in Portugal
Reis, A. C., Pinto, D., Monteiro, S., Santos, R., Martins, J. V., Sousa, A., Pascoa, R., Lourinho, R., Cunha, M. V.
10.1101/2023.10.30.23297774 — Posted: 2023-10-31
Two-years mothering into the pandemic: Impact of the three COVID-19 waves in the Argentinian postpartum womens mental health
Miranda, A. R., Scotta, A. V., Cortez, M. V., Soria, E. A.
10.1101/2023.10.30.23297772 — Posted: 2023-10-31
Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infection
Lee, Y.-C., Liu, L., Yuan, L., Risk, M., Heinrich, K., Witteveen-Lane, M., Hayek, S., Malosh, R., Pop-Busui, R., Jiang, B., Shen, C., Chesla, D., Kennedy, R., Shi, X., Sims, M., Homayouni, R., Zhao, L.
10.1101/2023.10.27.23297682 — Posted: 2023-10-31
Menstrual cycle changes increased following COVID-19 mRNA vaccination: Social media validation and self-controlled case series analysis.
Shetty, A. N., Kattan, G. S., Javed, M., Pearce, C., Clothier, H. J., Buttery, J. P.
10.1101/2023.10.26.23297643 — Posted: 2023-10-31
Nationwide population-based infection- and vaccine-induced SARS-CoV-2 seroprevalence in Germany at the end of 2021
Mercuri, E., Schmid, L., Poethko-Müller, C., Schlaud, M., Kussmaul, C., Ordonez-Cruickshank, A., Haller, S., Rexroth, U., Hamouda, O., Schaade, L., Wieler, L. H., Gösswald, A., Schaffrath Rosario, A., RKI-SOEP-2 Study Group|
10.1101/2023.10.30.23297594 — Posted: 2023-10-31
Serological markers and Post COVID-19 Condition (PCC): A rapid review of the evidence
Collins, E., Philippe, E., Gravel, C., Hawken, S., Langlois, M.-A., Little, J.
10.1101/2023.10.30.23297455 — Posted: 2023-10-30
Predictive factors of non-pharmacological measures to prevent SARS-CoV-2 contagion: A cross-sectional study in a large adult Spanish sample from PSY-COVID study
Mateo-Canedo, C., Sanabria-Mazo, J. P., Navarro, J. B., Cigarroa, I., Alvarez, M., Armayones, M., Martinez-Blanquet, L. J., Zapata-Lamana, R., Crespo Puig, N., Korniyenko, M., Sanz, A.
10.1101/2023.10.30.23297748 — Posted: 2023-10-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).